

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | peptide cross-linking (GO:0018149) | 9.80808156 |
| 2 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 8.86790241 |
| 3 | regulation of keratinocyte differentiation (GO:0045616) | 8.22738123 |
| 4 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 7.04583603 |
| 5 | response to vitamin A (GO:0033189) | 6.85240584 |
| 6 | regulation of relaxation of muscle (GO:1901077) | 6.69098895 |
| 7 | purine nucleotide salvage (GO:0032261) | 6.11600337 |
| 8 | muscle organ morphogenesis (GO:0048644) | 6.10648349 |
| 9 | keratinocyte differentiation (GO:0030216) | 6.06563228 |
| 10 | skeletal muscle contraction (GO:0003009) | 5.80861325 |
| 11 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.76271541 |
| 12 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 5.68383739 |
| 13 | regulation of cardioblast proliferation (GO:0003264) | 5.68383739 |
| 14 | regulation of skeletal muscle contraction (GO:0014819) | 5.56056394 |
| 15 | muscle filament sliding (GO:0030049) | 5.42332385 |
| 16 | actin-myosin filament sliding (GO:0033275) | 5.42332385 |
| 17 | regulation of skeletal muscle cell differentiation (GO:2001014) | 5.35998848 |
| 18 | innate immune response in mucosa (GO:0002227) | 5.29121820 |
| 19 | coronary vasculature morphogenesis (GO:0060977) | 5.21478438 |
| 20 | outer ear morphogenesis (GO:0042473) | 5.17369524 |
| 21 | tooth mineralization (GO:0034505) | 5.14765050 |
| 22 | linoleic acid metabolic process (GO:0043651) | 4.98432931 |
| 23 | regulation of epidermal cell differentiation (GO:0045604) | 4.92792443 |
| 24 | cellular response to epidermal growth factor stimulus (GO:0071364) | 4.84376866 |
| 25 | cellular response to retinoic acid (GO:0071300) | 4.77277387 |
| 26 | lymph vessel development (GO:0001945) | 4.63678162 |
| 27 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 4.48759757 |
| 28 | actin-mediated cell contraction (GO:0070252) | 4.37591936 |
| 29 | mucosal-associated lymphoid tissue development (GO:0048537) | 4.34519695 |
| 30 | Peyers patch development (GO:0048541) | 4.34519695 |
| 31 | lipoxygenase pathway (GO:0019372) | 4.20311111 |
| 32 | mucosal immune response (GO:0002385) | 4.12135877 |
| 33 | cellular response to glucocorticoid stimulus (GO:0071385) | 4.10773690 |
| 34 | epidermal cell differentiation (GO:0009913) | 4.10424566 |
| 35 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.04128550 |
| 36 | regulation of penile erection (GO:0060405) | 4.01225188 |
| 37 | creatine metabolic process (GO:0006600) | 4.00449293 |
| 38 | muscle cell fate commitment (GO:0042693) | 3.97738737 |
| 39 | response to epidermal growth factor (GO:0070849) | 3.97146242 |
| 40 | cellular response to corticosteroid stimulus (GO:0071384) | 3.95364440 |
| 41 | organ or tissue specific immune response (GO:0002251) | 3.88715038 |
| 42 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.86481979 |
| 43 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.86481979 |
| 44 | histamine secretion (GO:0001821) | 3.85218894 |
| 45 | embryonic viscerocranium morphogenesis (GO:0048703) | 3.80561965 |
| 46 | plasma membrane repair (GO:0001778) | 3.60918975 |
| 47 | skeletal muscle adaptation (GO:0043501) | 3.60690715 |
| 48 | positive regulation of protein depolymerization (GO:1901881) | 3.60510755 |
| 49 | positive regulation of myotube differentiation (GO:0010831) | 3.54799941 |
| 50 | establishment of skin barrier (GO:0061436) | 3.53837047 |
| 51 | negative regulation of B cell apoptotic process (GO:0002903) | 3.50365331 |
| 52 | cranial nerve morphogenesis (GO:0021602) | 3.46785323 |
| 53 | regulation of epidermis development (GO:0045682) | 3.46715881 |
| 54 | mature B cell differentiation involved in immune response (GO:0002313) | 3.44761067 |
| 55 | response to vitamin E (GO:0033197) | 3.42872901 |
| 56 | response to muscle activity (GO:0014850) | 3.39432541 |
| 57 | actin filament-based movement (GO:0030048) | 3.36027710 |
| 58 | striated muscle contraction (GO:0006941) | 3.33367968 |
| 59 | tricarboxylic acid cycle (GO:0006099) | 3.30329292 |
| 60 | myotube differentiation (GO:0014902) | 3.26924899 |
| 61 | regulation of germinal center formation (GO:0002634) | 3.26072135 |
| 62 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.24976090 |
| 63 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 3.23514269 |
| 64 | regulation of water loss via skin (GO:0033561) | 3.20428117 |
| 65 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.20297754 |
| 66 | positive regulation of skeletal muscle tissue development (GO:0048643) | 3.12946351 |
| 67 | skeletal muscle tissue regeneration (GO:0043403) | 3.12521566 |
| 68 | desmosome organization (GO:0002934) | 3.09975609 |
| 69 | skeletal muscle fiber development (GO:0048741) | 3.04793144 |
| 70 | myofibril assembly (GO:0030239) | 3.04458105 |
| 71 | histamine transport (GO:0051608) | 3.00974683 |
| 72 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.00676080 |
| 73 | keratinization (GO:0031424) | 20.9218506 |
| 74 | sarcomere organization (GO:0045214) | 2.94265962 |
| 75 | regulation of cell proliferation involved in heart morphogenesis (GO:2000136) | 2.91999219 |
| 76 | nucleotide salvage (GO:0043173) | 2.87619521 |
| 77 | aorta morphogenesis (GO:0035909) | 2.86929888 |
| 78 | purine nucleobase biosynthetic process (GO:0009113) | 2.84618815 |
| 79 | pharyngeal system development (GO:0060037) | 2.82307975 |
| 80 | adenosine metabolic process (GO:0046085) | 2.80551464 |
| 81 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.74356764 |
| 82 | carnitine shuttle (GO:0006853) | 2.73571220 |
| 83 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.70122664 |
| 84 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.70122664 |
| 85 | otic vesicle formation (GO:0030916) | 2.69452319 |
| 86 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.65071015 |
| 87 | epidermis development (GO:0008544) | 2.64950337 |
| 88 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.64021874 |
| 89 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.64016345 |
| 90 | negative regulation of circadian rhythm (GO:0042754) | 2.63153566 |
| 91 | multicellular organismal water homeostasis (GO:0050891) | 2.62729816 |
| 92 | aspartate family amino acid catabolic process (GO:0009068) | 2.61202923 |
| 93 | striated muscle adaptation (GO:0014888) | 2.58463685 |
| 94 | cochlea morphogenesis (GO:0090103) | 2.57484313 |
| 95 | positive regulation of protein complex disassembly (GO:0043243) | 2.57431375 |
| 96 | transcytosis (GO:0045056) | 2.56720262 |
| 97 | negative regulation of ion transmembrane transporter activity (GO:0032413) | 2.55675657 |
| 98 | cell wall macromolecule catabolic process (GO:0016998) | 14.6191148 |
| 99 | cell wall macromolecule metabolic process (GO:0044036) | 14.6191148 |
| 100 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 13.7809268 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 8.78444707 |
| 2 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 8.50811144 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.63232522 |
| 4 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.23845440 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.21293526 |
| 6 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.38777815 |
| 7 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.35960620 |
| 8 | CTCF_27219007_Chip-Seq_Bcells_Human | 2.31366064 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.16135110 |
| 10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.14521853 |
| 11 | CTCF_20526341_ChIP-Seq_ESCs_Human | 2.11532442 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.07533192 |
| 13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.02731729 |
| 14 | ERG_20517297_ChIP-Seq_VCAP_Human | 2.02198476 |
| 15 | VDR_22108803_ChIP-Seq_LS180_Human | 1.95800149 |
| 16 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.47362219 |
| 17 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.45882893 |
| 18 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.40956369 |
| 19 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.40733907 |
| 20 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.40073836 |
| 21 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.39524332 |
| 22 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.38447343 |
| 23 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.37431735 |
| 24 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.37323406 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.34843008 |
| 26 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.34015706 |
| 27 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.28197443 |
| 28 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.26528723 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25421210 |
| 30 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.24548072 |
| 31 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24314855 |
| 32 | CJUN_26792858_Chip-Seq_BT549_Human | 1.23301178 |
| 33 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.22901716 |
| 34 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.17857735 |
| 35 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.17781743 |
| 36 | RXR_22108803_ChIP-Seq_LS180_Human | 1.17512518 |
| 37 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.17316267 |
| 38 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.16491222 |
| 39 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16367481 |
| 40 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.14774701 |
| 41 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.14389576 |
| 42 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13246207 |
| 43 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11219541 |
| 44 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.11150086 |
| 45 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.10701104 |
| 46 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.10623917 |
| 47 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.10623917 |
| 48 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.08220601 |
| 49 | P68_20966046_ChIP-Seq_HELA_Human | 1.05686105 |
| 50 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04616883 |
| 51 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.04007659 |
| 52 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.01634401 |
| 53 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.01455587 |
| 54 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01333891 |
| 55 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.00192421 |
| 56 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.98346383 |
| 57 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.97999362 |
| 58 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.97971546 |
| 59 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97662816 |
| 60 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.96856729 |
| 61 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.96399732 |
| 62 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.93618527 |
| 63 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92354941 |
| 64 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.92250233 |
| 65 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.91883946 |
| 66 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.91778300 |
| 67 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.91697477 |
| 68 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.91448617 |
| 69 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.90637362 |
| 70 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.90174064 |
| 71 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.89353032 |
| 72 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.89031381 |
| 73 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.88912086 |
| 74 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88579906 |
| 75 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.86719599 |
| 76 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.85441198 |
| 77 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.85441198 |
| 78 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.85385533 |
| 79 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.85331386 |
| 80 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85304599 |
| 81 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84584879 |
| 82 | ERA_21632823_ChIP-Seq_H3396_Human | 0.84520570 |
| 83 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.84359446 |
| 84 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84072291 |
| 85 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.83509224 |
| 86 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.83436639 |
| 87 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.83387650 |
| 88 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.82929479 |
| 89 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.82896617 |
| 90 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.82533070 |
| 91 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.82168576 |
| 92 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.81960293 |
| 93 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.81906963 |
| 94 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.81780132 |
| 95 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.81672906 |
| 96 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80955949 |
| 97 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.80780081 |
| 98 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.80621831 |
| 99 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.79223142 |
| 100 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.78870161 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002234_abnormal_pharynx_morphology | 5.45705195 |
| 2 | MP0003646_muscle_fatigue | 5.17377100 |
| 3 | MP0000751_myopathy | 5.03655703 |
| 4 | MP0002796_impaired_skin_barrier | 5.01585057 |
| 5 | MP0005275_abnormal_skin_tensile | 4.39564717 |
| 6 | MP0000749_muscle_degeneration | 3.95356992 |
| 7 | MP0000467_abnormal_esophagus_morphology | 3.82753735 |
| 8 | MP0000762_abnormal_tongue_morphology | 3.33412086 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 3.30104345 |
| 10 | MP0009697_abnormal_copulation | 2.96521455 |
| 11 | MP0004145_abnormal_muscle_electrophysio | 2.96017665 |
| 12 | MP0005501_abnormal_skin_physiology | 2.74254740 |
| 13 | MP0000747_muscle_weakness | 2.70991245 |
| 14 | MP0002106_abnormal_muscle_physiology | 2.58508371 |
| 15 | MP0000759_abnormal_skeletal_muscle | 2.53306520 |
| 16 | MP0000678_abnormal_parathyroid_gland | 2.42862444 |
| 17 | MP0002095_abnormal_skin_pigmentation | 2.25823682 |
| 18 | MP0004185_abnormal_adipocyte_glucose | 2.16889237 |
| 19 | MP0003252_abnormal_bile_duct | 2.13877737 |
| 20 | MP0001243_abnormal_dermal_layer | 2.11242282 |
| 21 | MP0004087_abnormal_muscle_fiber | 2.11082688 |
| 22 | MP0005369_muscle_phenotype | 2.08020918 |
| 23 | MP0002254_reproductive_system_inflammat | 2.04626245 |
| 24 | MP0004036_abnormal_muscle_relaxation | 2.02730979 |
| 25 | MP0004130_abnormal_muscle_cell | 1.99695594 |
| 26 | MP0000750_abnormal_muscle_regeneration | 1.94681074 |
| 27 | MP0000733_abnormal_muscle_development | 1.91074684 |
| 28 | MP0002269_muscular_atrophy | 1.90645438 |
| 29 | MP0000371_diluted_coat_color | 1.85110869 |
| 30 | MP0010234_abnormal_vibrissa_follicle | 1.82741206 |
| 31 | MP0002249_abnormal_larynx_morphology | 1.70132435 |
| 32 | MP0005620_abnormal_muscle_contractility | 1.68325291 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.58652039 |
| 34 | MP0002332_abnormal_exercise_endurance | 1.56084803 |
| 35 | MP0004270_analgesia | 1.50143371 |
| 36 | MP0000470_abnormal_stomach_morphology | 1.45998564 |
| 37 | MP0005666_abnormal_adipose_tissue | 1.44190512 |
| 38 | MP0005330_cardiomyopathy | 1.37358685 |
| 39 | MP0006036_abnormal_mitochondrial_physio | 1.32433340 |
| 40 | MP0005266_abnormal_metabolism | 1.29833502 |
| 41 | MP0001879_abnormal_lymphatic_vessel | 1.28598759 |
| 42 | MP0000579_abnormal_nail_morphology | 1.25667395 |
| 43 | MP0003806_abnormal_nucleotide_metabolis | 1.24251310 |
| 44 | MP0002972_abnormal_cardiac_muscle | 1.21865986 |
| 45 | MP0002127_abnormal_cardiovascular_syste | 1.14759051 |
| 46 | MP0010771_integument_phenotype | 1.12541521 |
| 47 | MP0001216_abnormal_epidermal_layer | 1.08943380 |
| 48 | MP0004084_abnormal_cardiac_muscle | 1.08340523 |
| 49 | MP0004947_skin_inflammation | 1.03292761 |
| 50 | MP0000049_abnormal_middle_ear | 0.94760707 |
| 51 | MP0002108_abnormal_muscle_morphology | 0.92869053 |
| 52 | MP0002075_abnormal_coat/hair_pigmentati | 0.92328329 |
| 53 | MP0005375_adipose_tissue_phenotype | 0.91124676 |
| 54 | MP0004233_abnormal_muscle_weight | 0.90140593 |
| 55 | MP0002971_abnormal_brown_adipose | 0.88883379 |
| 56 | MP0003195_calcinosis | 0.88159430 |
| 57 | MP0005451_abnormal_body_composition | 0.86902553 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 0.83165210 |
| 59 | MP0004484_altered_response_of | 0.80744445 |
| 60 | MP0003453_abnormal_keratinocyte_physiol | 0.80689208 |
| 61 | MP0004215_abnormal_myocardial_fiber | 0.79785908 |
| 62 | MP0000647_abnormal_sebaceous_gland | 0.77859061 |
| 63 | MP0004043_abnormal_pH_regulation | 0.75348388 |
| 64 | MP0005385_cardiovascular_system_phenoty | 0.74377816 |
| 65 | MP0001544_abnormal_cardiovascular_syste | 0.74377816 |
| 66 | MP0001299_abnormal_eye_distance/ | 0.73094437 |
| 67 | MP0001191_abnormal_skin_condition | 0.72142516 |
| 68 | MP0002909_abnormal_adrenal_gland | 0.70354841 |
| 69 | MP0000372_irregular_coat_pigmentation | 0.68300318 |
| 70 | MP0002139_abnormal_hepatobiliary_system | 0.68071819 |
| 71 | MP0003221_abnormal_cardiomyocyte_apopto | 0.65053682 |
| 72 | MP0003329_amyloid_beta_deposits | 0.64642498 |
| 73 | MP0003950_abnormal_plasma_membrane | 0.64481529 |
| 74 | MP0009250_abnormal_appendicular_skeleto | 0.63350702 |
| 75 | MP0000367_abnormal_coat/_hair | 0.61971290 |
| 76 | MP0001346_abnormal_lacrimal_gland | 0.61808157 |
| 77 | MP0010630_abnormal_cardiac_muscle | 0.61492971 |
| 78 | MP0000427_abnormal_hair_cycle | 0.60678408 |
| 79 | MP0003566_abnormal_cell_adhesion | 0.60000367 |
| 80 | MP0009931_abnormal_skin_appearance | 0.59664269 |
| 81 | MP0006138_congestive_heart_failure | 0.57202791 |
| 82 | MP0000613_abnormal_salivary_gland | 0.56655907 |
| 83 | MP0000681_abnormal_thyroid_gland | 0.56539439 |
| 84 | MP0004858_abnormal_nervous_system | 0.56325628 |
| 85 | MP0008569_lethality_at_weaning | 0.54545957 |
| 86 | MP0001186_pigmentation_phenotype | 0.53446626 |
| 87 | MP0003755_abnormal_palate_morphology | 0.53157677 |
| 88 | MP0000343_altered_response_to | 0.52435945 |
| 89 | MP0008961_abnormal_basal_metabolism | 0.50145980 |
| 90 | MP0002060_abnormal_skin_morphology | 0.50018031 |
| 91 | MP0001177_atelectasis | 0.48703685 |
| 92 | MP0005319_abnormal_enzyme/_coenzyme | 0.48109229 |
| 93 | MP0005085_abnormal_gallbladder_physiolo | 0.47284130 |
| 94 | MP0003137_abnormal_impulse_conducting | 0.46500354 |
| 95 | MP0004859_abnormal_synaptic_plasticity | 0.45996377 |
| 96 | MP0003075_altered_response_to | 0.43077918 |
| 97 | MP0008775_abnormal_heart_ventricle | 0.40996950 |
| 98 | MP0003045_fibrosis | 0.40585567 |
| 99 | MP0002177_abnormal_outer_ear | 0.40489009 |
| 100 | MP0005165_increased_susceptibility_to | 0.38394330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Distal arthrogryposis (HP:0005684) | 6.55337646 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 6.44509006 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.42764700 |
| 4 | Exercise-induced myalgia (HP:0003738) | 6.23808670 |
| 5 | Nemaline bodies (HP:0003798) | 5.74788140 |
| 6 | Round ear (HP:0100830) | 5.38877957 |
| 7 | Ulnar deviation of the wrist (HP:0003049) | 5.29991129 |
| 8 | Exercise-induced muscle cramps (HP:0003710) | 4.92800008 |
| 9 | Type 1 muscle fiber predominance (HP:0003803) | 4.88583173 |
| 10 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.81508207 |
| 11 | Increased connective tissue (HP:0009025) | 4.79659632 |
| 12 | Absent phalangeal crease (HP:0006109) | 4.77293195 |
| 13 | Myopathic facies (HP:0002058) | 4.68405711 |
| 14 | Calf muscle hypertrophy (HP:0008981) | 4.66337711 |
| 15 | Difficulty running (HP:0009046) | 4.66004428 |
| 16 | Increased IgE level (HP:0003212) | 4.65717699 |
| 17 | Calcaneovalgus deformity (HP:0001848) | 4.56197537 |
| 18 | Myoglobinuria (HP:0002913) | 4.32673568 |
| 19 | Autoimmune thrombocytopenia (HP:0001973) | 4.24872547 |
| 20 | Muscle fiber splitting (HP:0003555) | 4.24101156 |
| 21 | Unilateral renal agenesis (HP:0000122) | 4.18338134 |
| 22 | Deformed tarsal bones (HP:0008119) | 4.05224091 |
| 23 | Hyporeflexia of lower limbs (HP:0002600) | 3.99107570 |
| 24 | Abnormal finger flexion creases (HP:0006143) | 3.94671234 |
| 25 | Rimmed vacuoles (HP:0003805) | 3.83343124 |
| 26 | Increased variability in muscle fiber diameter (HP:0003557) | 3.59820318 |
| 27 | Mesangial abnormality (HP:0001966) | 3.53643205 |
| 28 | Congenital malformation of the right heart (HP:0011723) | 3.44572767 |
| 29 | Double outlet right ventricle (HP:0001719) | 3.44572767 |
| 30 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.40742161 |
| 31 | Autoimmune hemolytic anemia (HP:0001890) | 3.40414653 |
| 32 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.34943307 |
| 33 | Right ventricular cardiomyopathy (HP:0011663) | 3.32520986 |
| 34 | Cholelithiasis (HP:0001081) | 3.26387975 |
| 35 | Abnormality of the aortic arch (HP:0012303) | 3.22728509 |
| 36 | Distal lower limb muscle weakness (HP:0009053) | 3.22332228 |
| 37 | Abnormality of the calf musculature (HP:0001430) | 3.14407415 |
| 38 | Muscle stiffness (HP:0003552) | 3.08597186 |
| 39 | Myotonia (HP:0002486) | 3.06198488 |
| 40 | EMG: myopathic abnormalities (HP:0003458) | 3.03577847 |
| 41 | Abnormality of the parathyroid morphology (HP:0011766) | 3.02843470 |
| 42 | Cupped ribs (HP:0000887) | 3.01719510 |
| 43 | Paralysis (HP:0003470) | 2.98685667 |
| 44 | Areflexia of lower limbs (HP:0002522) | 2.98359014 |
| 45 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.98085312 |
| 46 | Abnormal gallbladder morphology (HP:0012437) | 2.98032765 |
| 47 | Distal lower limb amyotrophy (HP:0008944) | 2.90005594 |
| 48 | Abnormality of the calcaneus (HP:0008364) | 2.85048378 |
| 49 | Hypoplastic ischia (HP:0003175) | 2.78529504 |
| 50 | Rhabdomyolysis (HP:0003201) | 2.78325021 |
| 51 | Hyperthyroidism (HP:0000836) | 2.75217859 |
| 52 | Neck muscle weakness (HP:0000467) | 2.73370589 |
| 53 | B lymphocytopenia (HP:0010976) | 2.68122221 |
| 54 | Abnormality of B cell number (HP:0010975) | 2.68122221 |
| 55 | Difficulty climbing stairs (HP:0003551) | 2.65941767 |
| 56 | Facial diplegia (HP:0001349) | 2.54606043 |
| 57 | Tetany (HP:0001281) | 2.50548893 |
| 58 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.44460215 |
| 59 | Abnormality of the ischium (HP:0003174) | 2.41794234 |
| 60 | Short palpebral fissure (HP:0012745) | 2.30754109 |
| 61 | Lower limb amyotrophy (HP:0007210) | 2.29888515 |
| 62 | Frequent falls (HP:0002359) | 2.27515223 |
| 63 | Hypoplastic left heart (HP:0004383) | 2.25101074 |
| 64 | Thyroiditis (HP:0100646) | 2.10951086 |
| 65 | Severe combined immunodeficiency (HP:0004430) | 2.09656624 |
| 66 | Shoulder girdle muscle weakness (HP:0003547) | 2.01116997 |
| 67 | Oral leukoplakia (HP:0002745) | 11.8136457 |
| 68 | Amblyopia (HP:0000646) | 1.99456513 |
| 69 | Scapular winging (HP:0003691) | 1.98755950 |
| 70 | Delusions (HP:0000746) | 1.97757721 |
| 71 | Pelvic girdle muscle weakness (HP:0003749) | 1.94610315 |
| 72 | Ectropion (HP:0000656) | 1.89515706 |
| 73 | Abnormality of the gallbladder (HP:0005264) | 1.88273503 |
| 74 | Wrist flexion contracture (HP:0001239) | 1.88252894 |
| 75 | Ulnar deviation of finger (HP:0009465) | 1.87622394 |
| 76 | Foot dorsiflexor weakness (HP:0009027) | 1.87155677 |
| 77 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.85390241 |
| 78 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.85390241 |
| 79 | Long clavicles (HP:0000890) | 1.84649931 |
| 80 | Nasal speech (HP:0001611) | 1.83681644 |
| 81 | Hyperkalemia (HP:0002153) | 1.83109113 |
| 82 | Seborrheic dermatitis (HP:0001051) | 1.80924123 |
| 83 | Muscular dystrophy (HP:0003560) | 1.80273279 |
| 84 | Combined immunodeficiency (HP:0005387) | 1.77494239 |
| 85 | Exotropia (HP:0000577) | 1.77490983 |
| 86 | Gangrene (HP:0100758) | 1.77095549 |
| 87 | Hypertensive crisis (HP:0100735) | 1.75675881 |
| 88 | Palmoplantar keratoderma (HP:0000982) | 1.75163933 |
| 89 | Gout (HP:0001997) | 1.70243477 |
| 90 | Achilles tendon contracture (HP:0001771) | 1.69598033 |
| 91 | Metatarsus adductus (HP:0001840) | 1.68884513 |
| 92 | Abnormality of the foot musculature (HP:0001436) | 1.67898762 |
| 93 | Hypoplastic heart (HP:0001961) | 1.66902354 |
| 94 | Woolly hair (HP:0002224) | 1.66011906 |
| 95 | Corneal erosion (HP:0200020) | 1.64137763 |
| 96 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.62921517 |
| 97 | Malignant hyperthermia (HP:0002047) | 1.62912628 |
| 98 | Abnormality of the Achilles tendon (HP:0005109) | 1.62262156 |
| 99 | Proximal amyotrophy (HP:0007126) | 1.57240348 |
| 100 | Abnormality of nail color (HP:0100643) | 1.56545433 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIK3CG | 4.90908289 |
| 2 | OBSCN | 3.83514715 |
| 3 | PHKG2 | 2.97779570 |
| 4 | PHKG1 | 2.97779570 |
| 5 | NEK1 | 2.93441712 |
| 6 | TRIB3 | 2.64940316 |
| 7 | PINK1 | 2.58935292 |
| 8 | PDK3 | 2.25616107 |
| 9 | PDK4 | 2.25616107 |
| 10 | MAP2K3 | 2.21507456 |
| 11 | TTN | 10.9288154 |
| 12 | MAPKAPK3 | 1.86251928 |
| 13 | BCKDK | 1.65811428 |
| 14 | PDK2 | 1.63727689 |
| 15 | DMPK | 1.57100434 |
| 16 | TAOK1 | 1.48521398 |
| 17 | NME1 | 1.45341153 |
| 18 | MAP3K7 | 1.25603300 |
| 19 | MAP2K4 | 1.20870302 |
| 20 | MAPK12 | 1.19349798 |
| 21 | PKN2 | 1.17486391 |
| 22 | KSR2 | 1.15342390 |
| 23 | MAP3K6 | 1.02189978 |
| 24 | MAP3K3 | 0.91968869 |
| 25 | FER | 0.87861173 |
| 26 | ERN1 | 0.87428510 |
| 27 | ERBB3 | 0.85220640 |
| 28 | DYRK1B | 0.83826493 |
| 29 | MAP2K6 | 0.80589129 |
| 30 | LATS2 | 0.78532158 |
| 31 | MAPK11 | 0.72161753 |
| 32 | EPHB1 | 0.71258268 |
| 33 | PAK6 | 0.69338042 |
| 34 | LRRK2 | 0.69239186 |
| 35 | LATS1 | 0.65643285 |
| 36 | CAMK2A | 0.64240170 |
| 37 | MAP3K9 | 0.63080682 |
| 38 | PRKD1 | 0.61833184 |
| 39 | RPS6KB2 | 0.60354720 |
| 40 | WNK4 | 0.56048111 |
| 41 | MUSK | 0.55187955 |
| 42 | MAP3K11 | 0.54135413 |
| 43 | LIMK1 | 0.54070300 |
| 44 | RIPK1 | 0.51965615 |
| 45 | PTK6 | 0.48226630 |
| 46 | MAP3K2 | 0.47899975 |
| 47 | SGK1 | 0.44453975 |
| 48 | PIK3CA | 0.44157731 |
| 49 | DDR2 | 0.42784030 |
| 50 | TRPM7 | 0.41514595 |
| 51 | CAMK2G | 0.39167551 |
| 52 | MAP3K1 | 0.38523091 |
| 53 | EEF2K | 0.37362913 |
| 54 | MAP2K1 | 0.36219375 |
| 55 | PRKAA2 | 0.31687418 |
| 56 | PRKCH | 0.30810803 |
| 57 | RET | 0.30638659 |
| 58 | PDPK1 | 0.29273771 |
| 59 | ROCK2 | 0.28137173 |
| 60 | DYRK3 | 0.26710808 |
| 61 | WNK1 | 0.26231804 |
| 62 | NTRK1 | 0.25545455 |
| 63 | EPHA3 | 0.25536078 |
| 64 | PDK1 | 0.25449513 |
| 65 | BMX | 0.25369389 |
| 66 | TAOK2 | 0.25194433 |
| 67 | PKN1 | 0.24255665 |
| 68 | PRKACA | 0.24242215 |
| 69 | MAP3K8 | 0.23536153 |
| 70 | RPS6KA3 | 0.23504861 |
| 71 | STK10 | 0.23034220 |
| 72 | ILK | 0.22753210 |
| 73 | ROCK1 | 0.22297444 |
| 74 | PAK3 | 0.21937218 |
| 75 | AKT2 | 0.20342268 |
| 76 | MOS | 0.19265296 |
| 77 | PRKG1 | 0.19257493 |
| 78 | SGK3 | 0.19113778 |
| 79 | MAPK4 | 0.18336462 |
| 80 | PDGFRA | 0.18076258 |
| 81 | MAPKAPK5 | 0.18063084 |
| 82 | TIE1 | 0.17675042 |
| 83 | PRKACB | 0.17165906 |
| 84 | PRKACG | 0.17164428 |
| 85 | JAK2 | 0.15013324 |
| 86 | MAPKAPK2 | 0.14911828 |
| 87 | MARK1 | 0.14823760 |
| 88 | EPHA4 | 0.14486890 |
| 89 | NTRK3 | 0.14482522 |
| 90 | CDK5 | 0.14152295 |
| 91 | ERBB4 | 0.12122065 |
| 92 | SGK223 | 0.11668996 |
| 93 | SGK494 | 0.11668996 |
| 94 | KSR1 | 0.11591828 |
| 95 | PRKD3 | 0.11113291 |
| 96 | BMPR2 | 0.11011413 |
| 97 | NEK9 | 0.10890908 |
| 98 | EPHB2 | 0.10737993 |
| 99 | SCYL2 | 0.10332633 |
| 100 | CDK19 | 0.09600103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Salivary secretion_Homo sapiens_hsa04970 | 4.45196886 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.43351784 |
| 3 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 4.12926026 |
| 4 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.08243164 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.47663985 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.16612966 |
| 7 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.72537203 |
| 8 | Histidine metabolism_Homo sapiens_hsa00340 | 2.66236529 |
| 9 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.25340900 |
| 10 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.22490039 |
| 11 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.07035439 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.86573643 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.81727143 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.72099582 |
| 15 | Carbon metabolism_Homo sapiens_hsa01200 | 1.68332828 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.67476778 |
| 17 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.50494297 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.49491132 |
| 19 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.45951073 |
| 20 | Alzheimers disease_Homo sapiens_hsa05010 | 1.45829465 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.37395287 |
| 22 | Olfactory transduction_Homo sapiens_hsa04740 | 1.35670578 |
| 23 | Parkinsons disease_Homo sapiens_hsa05012 | 1.33277897 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.32529971 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.32330217 |
| 26 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.27394141 |
| 27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24406642 |
| 28 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.24139854 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.22170641 |
| 30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.17350930 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.15767348 |
| 32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.15379243 |
| 33 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.14363834 |
| 34 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.11919605 |
| 35 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.10506331 |
| 36 | Phototransduction_Homo sapiens_hsa04744 | 1.07621517 |
| 37 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.97189185 |
| 38 | Renin secretion_Homo sapiens_hsa04924 | 0.94477384 |
| 39 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.94104797 |
| 40 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.87034840 |
| 41 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.86128382 |
| 42 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.86106854 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84412167 |
| 44 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.81637848 |
| 45 | Circadian entrainment_Homo sapiens_hsa04713 | 0.81601686 |
| 46 | Long-term potentiation_Homo sapiens_hsa04720 | 0.78128599 |
| 47 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.77336969 |
| 48 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.76949321 |
| 49 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.74197080 |
| 50 | Insulin resistance_Homo sapiens_hsa04931 | 0.70559375 |
| 51 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70290005 |
| 52 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69141681 |
| 53 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.62181668 |
| 54 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.61790406 |
| 55 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.61113499 |
| 56 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.60056609 |
| 57 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59739305 |
| 58 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.59425088 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58459827 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.57785356 |
| 61 | Glioma_Homo sapiens_hsa05214 | 0.57526460 |
| 62 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.55439715 |
| 63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.54154229 |
| 64 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53795745 |
| 65 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.52619925 |
| 66 | Melanogenesis_Homo sapiens_hsa04916 | 0.50006375 |
| 67 | Huntingtons disease_Homo sapiens_hsa05016 | 0.49946983 |
| 68 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.49808782 |
| 69 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.49753090 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46685027 |
| 71 | Long-term depression_Homo sapiens_hsa04730 | 0.42517952 |
| 72 | Pertussis_Homo sapiens_hsa05133 | 0.40994144 |
| 73 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.40377479 |
| 74 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.37920069 |
| 75 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.37865134 |
| 76 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.35544093 |
| 77 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.35226722 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34576582 |
| 79 | Tight junction_Homo sapiens_hsa04530 | 0.31455272 |
| 80 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.30511833 |
| 81 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.29800741 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29056036 |
| 83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.26936460 |
| 84 | Bile secretion_Homo sapiens_hsa04976 | 0.26442022 |
| 85 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.24910147 |
| 86 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.24465591 |
| 87 | Focal adhesion_Homo sapiens_hsa04510 | 0.22905430 |
| 88 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.18181701 |
| 89 | Metabolic pathways_Homo sapiens_hsa01100 | 0.18168426 |
| 90 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.17139041 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.16378882 |
| 92 | Peroxisome_Homo sapiens_hsa04146 | 0.16357137 |
| 93 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.14780621 |
| 94 | Platelet activation_Homo sapiens_hsa04611 | 0.14028315 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.13193695 |
| 96 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.12484711 |
| 97 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.12424530 |
| 98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.10708860 |
| 99 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.10642835 |
| 100 | GABAergic synapse_Homo sapiens_hsa04727 | 0.10434910 |

